Categories: Updates

BTF Now Offers Journal-based Continuing Medical Education (CME)

The Binaytara Foundation’s International Journal of Cancer Care & Delivery now publishes articles designed to provide continuing education credits as well as Medical Knowledge points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program to eligible learners.

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. In order to qualify for continuing education credits (CME) and/or the Medical Knowledge points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program (ABIM MOC Points), individual physicians must first study the related journal article and then register on the Binaytara Foundation’s continuing education portal and complete required post-tests and evaluations to claim the continuing medical education credits and/or the MOC points.

Physicians can access these journal articles either on the journal website itself or on the BTF continuing education portal. The International Journal of Cancer Care and Delivery (IJCCD) is an open-access (CC BY-SA) peer-reviewed online journal that publishes a wide range of scientific articles focused on improving the care of cancer patients by minimizing or eliminating barriers to care delivery. There is no fee to submit a manuscript to the International Journal of Cancer Care and Delivery (IJCCD).

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago